INDIANAPOLIS, Nov. 13, 2024 /PRNewswire/ -- Eli Lilly and Company (LLY) announced today detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed ...
A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...
Market Study on Overweight Treatment: Supplements Account for Nearly 90% Market Share. Overweight Treatment Market Segmented By Drug Treatment, Supplements, Medical Devices / Implants Treatment. Key ...
More adults are taking GLP-1 drugs to control their weight, despite recent shortages and high list prices, according to new research. The percentage of overweight or obese adults prescribed a GLP-1 ...
People who seek medical treatment for obesity or an eating disorder do so with the hope their health plan will pay for part of it. But whether it’s covered often comes down to a measure invented ...
The workshop featured invited presentations and discussions that explore what is known about current obesity treatment approaches and the challenges involved in implementing them, including their ...
Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...
Children and adolescents with Crohn disease with a high body mass index may require a higher dose of adalimumab. Pediatric patients with Crohn disease (CD) with a high body mass index (BMI) are more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results